MUTUAL FUND SERIES TRUST's AlphaCentric LifeSci Healthcare Fund (LYFCX) has disclosed 51 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2023-12-31. The current portfolio value is calculated to be $91.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 50%.
AlphaCentric LifeSci Healthcare Fund (LYFCX)'s
Total Assets is $104.64 Mil , Total Liabilities is $409,650.00 , Net Assets is $104.23 Mil.
In AlphaCentric LifeSci Healthcare Fund (LYFCX)'s current portfolio as of 2023-12-31, the top 5 holdings are
Galapagos NV (GLPG), BioCryst Pharmaceuticals Inc (BCRX), Pacira BioSciences Inc (PCRX), United Therapeutics Corp (UTHR) and Harmony Biosciences Holdings Inc (HRMY),
not including call and put options.
AlphaCentric LifeSci Healthcare Fund (LYFCX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for AlphaCentric LifeSci Healthcare Fund (LYFCX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for AlphaCentric LifeSci Healthcare Fund (LYFCX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for AlphaCentric LifeSci Healthcare Fund.